A pharmacokinetic analysis of plasma mycophenolic acid (MPA) levels in liver transplantation
โ Scribed by Attard, Thomas M.; Wise, Barbara V.; Conner, Kim; Alford, Mary K.; Colombani, Paul; Cuffari, Carmen
- Book ID
- 124137661
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 174 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The bioavailability of mycophenolic acid (MPA) after oral administration of mycophenolate mofetil (MMF) has been reported to be more than 90% in healthy volunteers, and in kidney and thoracic organ transplant patients. Such information is limited in liver transplant (LTx) patients. The present study
Mycophenolate mofetil (MMF) is a very powerful immunosuppressive drug used in preventing acute rejection in liver transplantation. However, MMF has some serious side effects, including hematologic and gastrointestinal disorders. This study was designed to investigate the relationship between the cli
The aim of the study was to evaluate the effect of t-tube clamping on the pharmacokinetics of mycophenolic acid (MPA) after oral administration of mycophenolate mofetil (MMF) in primary liver transplant recipients treated with tacrolimus as the primary immunosuppressive drug. We evaluated the pharma